Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita C R Perlingeiro

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Development (Cambridge, England)|July 20, 2007
Endoglin is required for hemangioblast and early hematopoietic developmentRita C R Perlingeiro
Journal of Stem Cell Research & Therapy|November 11, 2014
A Perspective on the Potential of Human iPS Cell-Based Therapies for Muscular Dystrophies: Advancements so far and Hurdles to OvercomeRadbod Darabi, Rita C R Perlingeiro
Advanced Drug Delivery Reviews|March 23, 2026
Progress on cell therapy for skeletal muscle disordersKarim Azzag, Rita C R Perlingeiro
Translational Research : the Journal of Laboratory and Clinical Medicine|December 5, 2013
Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocksFabrizio Rinaldi, Rita C R Perlingeiro
Cellular and Molecular Life Sciences : CMLS|July 8, 2022
Generation of human myogenic progenitors from pluripotent stem cells for in vivo regenerationHyunkee Kim, Rita C R Perlingeiro
Cell Cycle (Georgetown, Tex.)|June 28, 2008
Lineage-specific reprogramming as a strategy for cell therapyRadbod Darabi, Rita C R Perlingeiro
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2014
Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7Radbod Darabi, Rita C R Perlingeiro
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Culture and Electrophysiological Analysis of Patient-Specific iPSCs Using Microelectrode Array DishesBayardo I Garay, Rita C R Perlingeiro
Disease Models & Mechanisms|June 15, 2018
Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discoveryRicardo Mondragon-Gonzalez, Rita C R Perlingeiro
EMBO Molecular Medicine|December 8, 2022
Development of allogeneic iPS cell-based therapy: from bench to bedsideDavid H McKenna, Rita C R Perlingeiro
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Development (Cambridge, England)|July 20, 2007
Endoglin is required for hemangioblast and early hematopoietic developmentRita C R Perlingeiro
Journal of Stem Cell Research & Therapy|November 11, 2014
A Perspective on the Potential of Human iPS Cell-Based Therapies for Muscular Dystrophies: Advancements so far and Hurdles to OvercomeRadbod Darabi, Rita C R Perlingeiro
Advanced Drug Delivery Reviews|March 23, 2026
Progress on cell therapy for skeletal muscle disordersKarim Azzag, Rita C R Perlingeiro
Translational Research : the Journal of Laboratory and Clinical Medicine|December 5, 2013
Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocksFabrizio Rinaldi, Rita C R Perlingeiro
Cellular and Molecular Life Sciences : CMLS|July 8, 2022
Generation of human myogenic progenitors from pluripotent stem cells for in vivo regenerationHyunkee Kim, Rita C R Perlingeiro
Cell Cycle (Georgetown, Tex.)|June 28, 2008
Lineage-specific reprogramming as a strategy for cell therapyRadbod Darabi, Rita C R Perlingeiro
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2014
Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7Radbod Darabi, Rita C R Perlingeiro
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Culture and Electrophysiological Analysis of Patient-Specific iPSCs Using Microelectrode Array DishesBayardo I Garay, Rita C R Perlingeiro
Disease Models & Mechanisms|June 15, 2018
Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discoveryRicardo Mondragon-Gonzalez, Rita C R Perlingeiro
EMBO Molecular Medicine|December 8, 2022
Development of allogeneic iPS cell-based therapy: from bench to bedsideDavid H McKenna, Rita C R Perlingeiro
Pageof 9